Bafna Pharmaceuticals Quarterly Results for Trading Insights
BAFNAPH • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-1 Cr
QSept 2019
Bafna Pharmaceuticals Quarterly Results Key Highlights
- Revenue of ₹12 Cr in Sept 2019 (+71.4% vs Jun 2019, +33.3% vs Sept 2018)
- Net Profit of ₹-1 Cr in Sept 2019 (+50.0% vs Jun 2019, +0.0% vs Sept 2018)
- Operating Margin of -3.0% in Sept 2019 (+39.0pp vs Jun 2019)
- Earnings Per Share of ₹-0.25 in Sept 2019 (+72.2% vs Jun 2019)
Bafna Pharmaceuticals Quarterly Results Analysis
| Metric | Sept 2019 | Jun 2019 | Sept 2018 | Jun 2018 | QoQ | YoY |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 12 | 7 | 9 | 12 | 71.4% | 33.3% |
| Net Profit (₹ Cr) | -1 | -2 | -1 | -4 | - | - |
| EBITDA (₹ Cr) | 0 | -3 | 0 | -2 | - | - |
| EPS (₹) | -0.25 | -0.90 | -0.80 | 0.00 | - | - |
| Operating Margin (%) | -3.0% | -42.0% | 2.0% | -15.0% | - | - |
Bafna Pharmaceuticals Share Price Trend Around Quarterly Results
Visualize Bafna Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Bafna Pharmaceuticals share price
chart using Tickjournal. All values in ₹.
Related Pages for Bafna Pharmaceuticals
Additional stock information and data for BAFNAPH
Revenue Trend (₹ Cr)
Jun 2018
12
Sept 2018
9
Jun 2019
7
Sept 2019
12
Net Profit Trend (₹ Cr)
Jun 2018
-4
Sept 2018
-1
Jun 2019
-2
Sept 2019
-1
Operating Margin Trend (%)
Jun 2018
-15.0%
Sept 2018
2.0%
Jun 2019
-42.0%
Sept 2019
-3.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Bafna Pharmaceuticals quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹391,547.47 Cr | 1702.1 | 14,875 | 3,125 | +10.8% | - | 21.0% | 130.9 |
|
Divis Laboratories
Sept 2025 |
₹160,887.23 Cr | 6209.0 | 2,860 | 689 | +7.1% | - | 24.1% | 239.1 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,071.99 Cr | 4045.6 | 3,219 | 591 | +11.3% | - | 18.4% | 230.6 |
|
Cipla
Sept 2025 |
₹110,697.00 Cr | 1322.8 | 7,716 | 1,353 | +12.0% | - | 17.5% | 79.1 |
|
Dr Reddys Laborator…
Sept 2025 |
₹103,126.93 Cr | 1235.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 76.4 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores